Linzhi Han

发表

Tumor Microenvironment-based Gene Signatures Divides Novel Immune and Stromal Subgroup Classification of Lung Adenocarcinoma

C. Xie, Jiali Li, Z. Zeng, 2019, 1905.03978.

Hollow PtCo alloy nanospheres as a high-Z and oxygen generating nanozyme for radiotherapy enhancement in non-small cell lung cancer.

Yuan Luo, C. Xie, Xueping Jiang, 2021, Journal of materials chemistry. B.

RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma

C. Xie, Jiali Li, Xingyu Liu, 2021, Cell & bioscience.

MUC3A induces PD-L1 and reduces tyrosine kinase inhibitors effects in EGFR-mutant non-small cell lung cancer

Yuan Luo, Yu Xiao, Yingming Sun, 2021, International journal of biological sciences.

SETD2 regulates gene transcription patterns and is associated with radiosensitivity in lung adenocarcinoma

Jianguo Zhang, C. Xie, Jiali Li, 2022, Frontiers in Genetics.

Downregulation of Nitric Oxide Collaborated with Radiotherapy to Promote Anti-Tumor Immune Response via Inducing CD8+ T Cell Infiltration

Yuan Luo, Yingming Sun, C. Xie, 2020, International journal of biological sciences.

PARP inhibitor plus radiotherapy reshapes an inflamed tumor microenvironment that sensitizes small cell lung cancer to the anti-PD-1 immunotherapy.

Jinfang Zhang, Yuan Luo, C. Xie, 2022, Cancer letters.

Nanoscale Zeolitic Imidazolate Framework (ZIF)–8 in Cancer Theranostics: Current Challenges and Prospects

Mengqin Wang, Yuzhou Wu, C. Xie, 2022, Cancers.

Retrospective study of gene signatures and prognostic value of m6A regulatory factor in non-small cell lung cancer using TCGA database and the verification of FTO

Linzhi Han, Jinping Zhao, Hongjie Shi, 2020, Aging.

Agrin Promotes Non-Small Cell Lung Cancer Progression and Stimulates Regulatory T Cells via Increasing IL-6 Secretion Through PI3K/AKT Pathway

Yuan Luo, C. Xie, Xueping Jiang, 2022, Frontiers in Oncology.

GPR87 promotes tumor cell invasion and mediates the immunogenomic landscape of lung adenocarcinoma

Jianguo Zhang, C. Xie, Y. Gong, 2022, Communications Biology.

Mechanisms and management of 3rd-generation EGFR-TKI resistance in advanced non-small cell lung cancer (Review)

C. Xie, Y. Gong, Zhengrong Huang, 2021, International journal of oncology.

Novel immune and stromal subtype classification system of lung adenocarcinoma based on tumor microenvironment

C. Xie, Jiali Li, Z. Zeng, 2019, bioRxiv.

Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma

Yuan Luo, C. Xie, Xueping Jiang, 2020, Cancer medicine.

Tumor stemness and immune infiltration synergistically predict response of radiotherapy or immunotherapy and relapse in lung adenocarcinoma

Linzhi Han, Jinping Zhao, Hongjie Shi, 2021, Cancer medicine.

HHLA2 deficiency inhibits non‐small cell lung cancer progression and THP‐1 macrophage M2 polarization

Yuan Luo, Junhong Zhang, C. Xie, 2021, Cancer medicine.

Ataxia telangiectasia mutated kinase inhibition promotes irradiation‐induced PD‐L1 expression in tumour‐associated macrophages through IFN‐I/JAK signalling pathway

C. Xie, Y. Gong, Zhengrong Huang, 2022, Immunology.

SETD2 mediates immunotherapy and radiotherapy efficacy via regulating DNA damage responses and genomic stability in lung adenocarcinoma

Jianguo Zhang, C. Xie, Jiali Li, 2022, Genes & diseases.

Pan-cell death-related signature reveals tumor immune microenvironment and optimizes personalized therapy alternations in lung adenocarcinoma

Linzhi Han, Conghua Xie, Jingyi He, 2024, Scientific reports.

Molecular classification reveals the sensitivity of lung adenocarcinoma to radiotherapy and immunotherapy: multi-omics clustering based on similarity network fusion

Junhong Zhang, Fajian He, Linzhi Han, 2024, Cancer immunology, immunotherapy : CII.

hsa-miR-1301-3p Promotes the Proliferation and Migration of Nonsmall Cell Lung Cancer Cells and Reduces Radiosensitivity via Targeting Homeodomain-Only Protein Homeobox.

Wen-jie Sun, Zhengrong Huang, Linzhi Han, 2023, Genetic testing and molecular biomarkers.

Targeting the LMP1-ALIX axis in EBV+ nasopharyngeal carcinoma inhibits immunosuppressive small extracellular vesicle secretion and boosts anti-tumor immunity.

Fajian He, Yanping Gao, Linzhi Han, 2024, Cancer communications.